Latest Trials

EudraCT Number: 2008-003600-55 Sponsor Protocol Number: ALN-RSV01-106 Start Date:
Sponsor Name: Alnylam Pharmaceuticals, Inc.
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected ...
Medical condition: Lung transplant patients with Human respiratory syncytial virus (RSV) infection
Disease: Version SOC Term Classification Code Term Level
9.1 10052200 Respiratory syncytial virus infection NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe